Our Mino-Wrap product (CITI-101) is a malleable, bio-absorbable film impregnated with minocycline and rifampin. It is designed to reduce infections associated with the use of breast tissue expanders (TE) used in breast reconstruction surgeries following mastectomies.
Mino-Wrap is placed over or wrapped around the TE in the surgical pocket as a solid film. It swells and liquefies in situ for a specified period of time providing extended protection against infection from the most likely pathogens. In January 2019, Citius signed a definitive worldwide license agreement with The University of Texas MD Anderson Cancer Center to develop and commercialize this novel approach to reducing postoperative infections associated with surgical implants. Mino-Wrap is being reviewed by the FDA’s Center for Drug Evaluation and Research (“CDER”) division.